These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2837930)

  • 1. Nervous system complications in uremia.
    Fraser CL; Arieff AI
    Ann Intern Med; 1988 Jul; 109(2):143-53. PubMed ID: 2837930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.
    Fraser CL; Arieff AI
    New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremic encephalopathies: clinical, biochemical, and experimental features.
    Mahoney CA; Arieff AI
    Am J Kidney Dis; 1982 Nov; 2(3):324-36. PubMed ID: 6756130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic complications of renal disease.
    Lockwood AH
    Neurol Clin; 1989 Aug; 7(3):617-27. PubMed ID: 2549362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
    Avram MM; Feinfeld DA; Huatuco AH
    N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic neuropathy: correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum.
    Aiello I; Serra G; Gilli P; Rosati G; Manca M; De Bastiani P; Fagioli F
    Eur Neurol; 1982; 21(6):396-400. PubMed ID: 6293832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of dialysis encephalopathy.
    Arieff AI; Mahoney CA
    Neurobehav Toxicol Teratol; 1983; 5(6):641-4. PubMed ID: 6366603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic disorders in renal failure (second of two parts).
    Raskin NH; Fishman RA
    N Engl J Med; 1976 Jan; 294(4):204-10. PubMed ID: 172790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurological complications in uremia].
    Fong CS
    Acta Neurol Taiwan; 2008 Jun; 17(2):117-26. PubMed ID: 18686653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone and uremic neurotoxicity: an unproven association.
    Arieff AI; Armstrong DK
    Contrib Nephrol; 1980; 20():56-66. PubMed ID: 6995013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurologic complications in hemodialysis patients].
    Goulon-Goeau C; Saïd G
    Rev Prat; 1990 Mar; 40(7):644-6. PubMed ID: 2326590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic complications in uremia].
    Halvorsen S; Refvem T
    Tidsskr Nor Laegeforen; 1979 Sep; 99(26):1252-4. PubMed ID: 227134
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity of parathyroid hormone in uremia.
    Klahr S; Slatopolsky E
    Annu Rev Med; 1986; 37():71-8. PubMed ID: 3010810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum an uremic toxin.
    D'Haese PC; Van de Vyver FL; Lamberts LV; De Broe ME
    Adv Exp Med Biol; 1987; 223():89-96. PubMed ID: 3447454
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of a 1100-1300 MW uremic neurotoxin.
    Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
    Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
    [No Abstract]   [Full Text] [Related]  

  • 17. Nervous system disorders in dialysis patients.
    Bansal VK; Bansal S
    Handb Clin Neurol; 2014; 119():395-404. PubMed ID: 24365308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uremic neuropathy--I. Is uremic neuropathy related to patient age, duration of nephropathy and dialysis treatment?].
    Jedras M; Zakrzewska-Pniewska B; Wardyn K; Switalski M
    Pol Arch Med Wewn; 1998 Jun; 99(6):452-61. PubMed ID: 10085699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotin in the management of uremic neurologic disorders.
    Yatzidis H; Koutsicos D; Agroyannis B; Papastephanidis C; Francos-Plemenos M; Delatola Z
    Nephron; 1984; 36(3):183-6. PubMed ID: 6322032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic toxins, and their effect on intermediary metabolism.
    Wills MR
    Clin Chem; 1985 Jan; 31(1):5-13. PubMed ID: 3880681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.